{{multiple issues|
{{context|date=April 2014}}
{{one source|date=April 2014}}
{{Underlinked|date=June 2016}}
}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477852809
| IUPAC_name = 3-(diphenylmethylene)-1,1-diethyl-2-methylpyrrolidinium bromide
| image = Prifinium bromide.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|prifinium-bromide}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 4630-95-9
| ATC_prefix = A03
| ATC_suffix = AB18
| PubChem = 20749
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 19537
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 3B7O9ZC520
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1213353

<!--Chemical data-->
| C=22 | H=28 | Br=1 | N=1 
| molecular_weight = 386.37 g/mol
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H28N.BrH/c1-4-23(5-2)17-16-21(18(23)3)22(19-12-8-6-9-13-19)20-14-10-7-11-15-20;/h6-15,18H,4-5,16-17H2,1-3H3;1H/q+1;/p-1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UCGJZJXOPSNTGZ-UHFFFAOYSA-M
}}

'''Prifinium bromide''' is an [[antimuscarinic]].<ref>{{Cite journal 
| last1 = Magalini | first1 = M. 
| last2 = Monica | first2 = F. 
| title = Use of prifinium bromide in endoscopic premedication. A double-blind controlled study vs hyoscine N-butylbromide 
| journal = Minerva gastroenterologica e dietologica 
| volume = 41 
| issue = 2 
| pages = 197â€“202 
| year = 1995 
| pmid = 7647144
}}</ref>

==References==
{{reflist}}

{{Drugs for functional gastrointestinal disorders}}
{{Muscarinic acetylcholine receptor modulators}}

{{DEFAULTSORT:Prifinium Bromide}}

[[Category:Muscarinic antagonists]]
[[Category:Quaternary ammonium compounds]]
[[Category:Pyrrolidines]]
[[Category:Alkene derivatives]]


{{gastrointestinal-drug-stub}}